146 related articles for article (PubMed ID: 503288)
1. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
[No Abstract] [Full Text] [Related]
2. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
Farrari C; Telloli P; Rampini P; Caldara R
Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
[TBL] [Abstract][Full Text] [Related]
4. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperprolactinemic amenorrhea with Metergoline.
Bohnet HG; Kato K; Wolf AS
Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
[TBL] [Abstract][Full Text] [Related]
6. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
[TBL] [Abstract][Full Text] [Related]
8. [Methergoline therapy of hyperprolactinemic amenorrhea. Observations on 22 cases].
Rossetti MG; Belforte L; Bruno M; Lanza MG; Peris C; Vaudano G; Campagnoli C
Minerva Ginecol; 1981 Jun; 33(6):586-9. PubMed ID: 7279283
[No Abstract] [Full Text] [Related]
9. Metergoline as an alternative to bromocriptine in amenorrhoea.
Hicks BH; Finer N; Herbert LC
Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
[TBL] [Abstract][Full Text] [Related]
10. Metergoline treatment of hyperprolactinemic states.
Crosignani PG; Ferrari C; Mattei A; Fadini R; Meschia M; Caldara R; Rampini P; Telloli P; Reschini E
Fertil Steril; 1979 Sep; 32(3):280-5. PubMed ID: 488408
[No Abstract] [Full Text] [Related]
11. Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.
Falsetti L; Voltolini AM; Crosignani PG; Lotti G; Travaglini P; Faglia G; Cianci A; Palumbo G; Praga C; Pontiroli AE
Gynecol Obstet Invest; 1982; 13(2):108-16. PubMed ID: 7035305
[TBL] [Abstract][Full Text] [Related]
12. [Results of different types of treatment in prolactin adenoma].
Leal Cerro A; García-Luna PP; Astorga Jiménez R; Acosta Delgado D; Santos Español C; Villamil F
Med Clin (Barc); 1985 Dec; 85(20):823-6. PubMed ID: 4087967
[No Abstract] [Full Text] [Related]
13. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
Falsetti L; Scagliola P; Turla R; Voltolini AM
Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256
[TBL] [Abstract][Full Text] [Related]
14. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Mussa A; Sandrucci S; Dogliotti L
Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
[TBL] [Abstract][Full Text] [Related]
15. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
16. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G
Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
Schneider WH; Huber H; Spona J
Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
[TBL] [Abstract][Full Text] [Related]
18. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
Delitala G
Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
[TBL] [Abstract][Full Text] [Related]
19. [Hyperprolactinemic amenorrhea and sterility treated with bromocriptine].
Polishuk WZ; Yarkoni S; Ben-David M; Spitz J
Harefuah; 1975 Dec; 89(11):500-3. PubMed ID: 1205386
[No Abstract] [Full Text] [Related]
20. Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study.
Blackwell RE; Bradley EL; Kline LB; Duvall ER; Vitek JJ; DeVane GW; Chang RJ
Fertil Steril; 1983 Jun; 39(6):744-8. PubMed ID: 6343127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
